DAFTAR PUSTAKA
Aithal, P.G., Day, C.P., 1999, The Natural History of Histologically Proved Drug Induced Liver Disease. GUT, 44:731–735.
Andreasen, P.B., Handel, J., Greisen, G., Hvidberg, E.F., 1976, Pharmacokinetics of diazepam in disorder liver function, European Journal of Clinical Pharmacology, 10:115-120
Arinzon, Z., Arinzon, P., Berner, Y., 2004, Hydrochlorothiazide induced cholestatic liver injury, Age and Ageing, 1-2
Badan POM RI, 2008, Informatorium Obat Nasional Indonesia, Jakarta.
Caldwell, S.H., Hespenheide, E.E., Borstel, R.W., 2001, Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin. Digest Dis Sci.; 46: 376.
Cinthya, S.E., Ivan, S.P., dan Rizky, A., 2012, Penggunaan Obat Penginduksi Kerusakan Hati pada Pasien Rawat Inap Penyakit Hati di Salah Satu Rumah Sakit di Kota Tasikmalaya, Jurnal Farmasi Klinik Indonesia, 1 (2).
Conant, R., Schauss, A.G., 2004, Therapeutic Applications of Citicoline for Stroke and Cognitive Dysfunction in the Elderly: A Review of the Literature, Alternative Medicine Review, 9:17-31.
Costinela, G., Mihai, N., 2012, Research On Ceftazidime - Induced Neurotoxicity In -Patients With Renal Diseases, Fascicula XVII, 2:55-58
Department of Health and Human Services Food and Drug Administration, 2009, Guidance for Industry Drug-Induced Liver Injury: Premarketing Clinical Evaluation, Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER), US.
Depkes RI, 2003, Farmakologi jilid II, Departemen Kesehatan RI, Jakarta.
Depkes RI, 2007, Pharmaceutical Care untuk Penyakit Hati, Departemen Kesehatan RI, Jakarta.
Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., and Posey, L. M., 2005. Pharmacotherapy Handbook Sixth. McGraw-Hill Company. USA.
Dourakis SP, 2008, Drug Therapy in Liver Diseases. Annals Of Gastroenterology, 21(4) : 215- 217.
Ehrenpreis, S., Ehrenpreis E.D., 2001, Clinician’s handbook of Prescription Drugs: McGraw-Hill Companies.
Fancher, T.L., Kamboj, A., Onate, J., 2007, Patients’ elevated LFT results can indicate hepatocyte injury, cholestasis, or both, Current Psychiatry, 6(5): 61-68
Fontana, B.J., Shakil, O., Greenson, J.K., Boyd, I., & Lee, W.M., 2005, Acute Liver Failure Due to Amoxocillin and Amoxicillin/Clavulanate, Digestive Dideases and Sciences, 50(10);1785-1790.
Friedman, S.L., 2008, Clinins in Liver Disease, Division of liver diseases, NewYork.
Ganong, W.F., 2008. Buku Ajar Fisiologi Kedokteran. Jakarta : EGC. pp : 519.
Gerber, T., Schomerus, H., 2000, Hepatic Encephalopathy in Liver Cirrhosis: pathogenesis, diagnosis, and management. Drugs; 60(6): 1353-7
Guy, J. & Peters, M. G., 2013, Liver Disease in Women: The Influence of Gender on Epidemiology, Natural History, and Patient Outcomes, Gastoenterology and Hepatology, 9, 10
Grattagliano, I., Leonilde Bonfrate, Catia V Diogo, Helen H Wang, David QH Wang, and Piero Portincasa. 2009. Biochemical mechanisms in drug-induced liver injury: Certainties and doubts. World J Gastroenterol. 15(39): 4865–4876.
Grieco, A., et al, 2005, Fatty liver and Drugs, Europen Review for Medical and Pharmacological Sciences, 9: 261-263.
Grimbert, S., Pessayre, D., Degott C., Benhamou, J.P., 2006, Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin. Digest Dis Sci.; 39: 2032–2033.
Hadari, Nawawi., 2005, Metode Penelitian Bidang Sosial, Yogyakarta: Gadjah Mada University Press.
Hussein, Z., Granneman, G.R., Mukherjee, D, 2008, Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole, Br. J. Clin.
Pharmacol, 36: 391–8.
Isabel, M., et al, 2008, Assessment of drug-induced liver injury in clinical practice Assessment of drug-induced liver injury in clinical practice, Agencia Espan˜-ola del Medicamento and from the Fondo de Investigacio´ n Sanitaria.
John R. Senior. 2005. Recognizing Drug-Induced Liver Injury (DILI) in Exposed Populations. Pharmacoepidemiology and Statistical Science Food and Drug Administration (FDA). United State of America.
Kanathur, N., Mathai, M.G., Byrd, R.P., Fields, C.L., Roy, T.M., 2001, Simvastatin- Diltiazem drug interaction resulting in rhabdomyolysis and hepatitis. Tennessee Med.; 94: 339–341.
Kaplan, L.A., Pesce JA, 1989, Clinical Chemistry: Theory Analysis and Corelation. Edisi ke-3, New York: Mosby.
Kaplowitz, N., 2007, Drug-Induced Liver Disease. Second Edition. Informa Healthcare USA, Inc. New York. 1-717.
Koolman, J,.Rohm., K.H., 1995, Atlas Berwarna dan Teks Biokimia. Wanandi SI, penerjemah; Jakarta: Hipokrates. Terjemahan dari: Color Atlas of Biochemistry.
Kshirsagar, A., Vetal, Y., Ashok, P., Bhosle, P., and Ingawale, D., Drug Induced Hepatotoxicity: A Comprehensive Review. The Internet Journal of Pharmacology. 2008 Volume 7 Number 1.
Larson, A.M., et al. 2005. Acetaminophen-Induced Acute Liver Failure: Results of a United States Multicenter, Prospective Study. Hepatology. 42:1364-1372.
Lawrence SF.Liver, 2003, Current Medical Diagnosis & Treatment. San Fransisco: McGraw Hill,628:73
Lee D., 2012, Drug Induced Liver Disease. URL : www.medicineNet.com. July, 26.
Lucena, M.I., Cortes, M.G., Cueto, R., Duran, J.L.L., dan Andrade, R.J., 2008, Assessment of Drug Induced Injuy in Clinical Practice, Fundamental & Clinical Pharmacology, 10.
Magueur, R., Hagege, H., Attali, P., Singlas, E., Etienne, J.P., & Taburet, A.m., 1991, Pharmacokinetics of Metoclopramide in Patients with Liver Cirrhosis, Br J clin Pharmac, 31;185-187.
Martin, D.W., Mayes, P.A., Rodwell, V.W., 1984, Biokimia, Dharma A, Kurniawan AS; Jakarta: EGC Penerbit Buku Kedokteran. Terjemahan dari: Review of Biochemistry.
Mengel, M.B., 1996, Family Medicine Ambulatory Care & Prevention 4 th edition, Mc Graw Hill Boston-London-Singapore-Toronto. p. 268-272.
MIMS, 2008, MIMS Indonesia Petunjuk Konsultasi, Edisi 8, Jakarta.
Moore, K.P., Aithal, G.P., 2006, Guidelines on the Management of Ascites in Cirrhosis, Gut BMJ Journals, 55; 1-12.
Murray, K.F., 2008, Drug Related Hepatotoxicity and Acute Liver Failure, Journal of Pediatric Gastroenterology and Nutrition, 47: 395-405.
Nakad, A., Bataille, L., Hamoir, V., Sempoux, C., Horsman, Y., 1999, Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin. Lancet.; 353: 1763–1764.
Navarro, VJ., dan Senior, J.R., 2006, Drug Related hepatotoxicity, N England Journal Med, 354, 731.9
Ndraha, S., 2013, Kolestasis Intrahepatik, Ckd-207, 40: 567-561.
Nederlands Bijwerkingen Centrum Lareb, 2013, Ceftriaxone and Hepatitis, Nederlands Bijwerkinged Centrun Nederland Pharmacovigilance Center.
Nurjanah S. Sirosis hati, 2007, Ilmu penyakit dalam. Jakarta: Pusat Penerbitan Fakultas Kedokteran Universitas Indonesia, 443:46
Oktaviani, I., 2012, Aspek Farmakokinetik Klinik Obat-Obatan yang Digunakan Pasien Sirosis Hati di Bangsal Interne RSUP Dr. M. Djamil Padang Periode Oktober 2011- Januari 2012, Laporan Penelitian, Padang.
Pelli, N., Setti, M., Cepp,,a P., Toncini C., Indiveri. F., 2003, Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroen Hepat.; 15: 921-924.
Prescott, L.F., Wright, N., Roscoe, P. & Brown, S.S., 1971, Plasma Paracetamol Half-Life and Hepatic Necrosis in Patients with Paracetamol Overdose, Lancet, i, 519-522.
Reuben, A., Koch, D.G., Lee, W.M., 2010, Drug-Induced Acute Liver Failure: results of a U.S. Multicenter Prospective Study, Hepatology, 2076.
Rosenberg, L., et al, 1980, Thiazides and Acute Cholecystitis, N Engl J Med,303:548.
Setiabudy, R., 1979, Hepatitis Karena Obat, Cermin Dunia Kedokteran,15: 8-12.
Simmons, F., Feldman, B., and Gerety, B., 1972, Granulomatous Hepatitis In A Patient Receiving Allopurinol, Gastroenterology. 62(1).
Sonderup, M.W., 2006, Drug Induced Liver Injury is a Significant Cause of Liver Disease, Including Chronic Liver, Drug Induced Liver Injuries, 29(6).
Sutadi, S.M., 2003, Sirosis Hepatitis, Bagian Ilmu Penyakit Dalam, FK Sumatera Utara.
Tajiri K and Shimizu Y. 2008. Practical Guidelines for Diagnosis and Early Management of Drug-Induced Liver Injury. World J Gastroenterol. 14(44): 6774–6785
Tandon, R.K., 2012, Prescribing in patients with liver disease, Medicine Update. 22, 294-297.
Thomson, A.B.R., Shaffer, E.A., 2012, First Principles of Gastroenterologt the Basis of Disease and an Approach to Management, Gastroenterology, 5:(525).
Tibesar, E., Karwowski, C., Hertel, P., Scheimann, A., and Karnsakul, W., 2014, Two Cases of Progressive Familial Intrahepatic Cholestasis Type 2 Presenting with Severe Coagulopathy without Jaundice, Case Reports in Pediatrics,:1-5
Timbrell, J., A., 1983, Drug Hepatotoxocity, Br J clin Pharmacology, 15, 3-14.
Topal, F., Ersan. O., Sabiye.A., Metin. K., Osman, Y., Emin. A., 2006, Methylprednisolone-induced toxic hepatitis. Ann Pharmacother 40(10): 1868-1871.
Urata, Y., Okita, K., Korenaga, K., Uchida, K., Yamasaki, T., Sakaida, I., 2007, The effect of supplementation with branched chain amino acids in patients with liver cirrhosis, Hepatol Res,37(7):510:6
Wai, CT., 2006, Presentation of drug-induced liver injury in Singapore, Singapore Medical Journal, 47(2) : 116.
Whitcomb, D.C & Block, G.D. 1994. Association of Acetaminophen Hepatotoxicity with Fasting and Ethanol Use. JAMA, 272: 1845–50.
Vatansever, S., 2012, Irbesartan-induced autoimmune hepatitis, akademik
gastroenteroloji dergisi, 11 (1): 35-38.
Verma,S., Kaplowitz, N., 2009, Diagnosis, Management and Prevention of Drug-Induced Liver Injury, Department of Medicine, Brighton and Sussex Medical School, Brighton, UK.
Vial T, Goubier C, Bergeret A, Cabrera F, Evreux JC, and Descotes J., 1991, Side Effects of Ranitidine. Drug Saf 6:94–117.
